H. M. Aytac Et Al. , "Tumor Necrosis Factor-alpha (TNF-α) −238 G/A Polymorphism Is Associated with the Treatment Resistance and Attempted Suicide in Schizophrenia," Immunological Investigations , vol.51, no.2, pp.368-380, 2022
Aytac, H. M. Et Al. 2022. Tumor Necrosis Factor-alpha (TNF-α) −238 G/A Polymorphism Is Associated with the Treatment Resistance and Attempted Suicide in Schizophrenia. Immunological Investigations , vol.51, no.2 , 368-380.
Aytac, H. M., ÖZDİLLİ, K., Tuncel, F. C., Pehlivan, M., & PEHLİVAN, S., (2022). Tumor Necrosis Factor-alpha (TNF-α) −238 G/A Polymorphism Is Associated with the Treatment Resistance and Attempted Suicide in Schizophrenia. Immunological Investigations , vol.51, no.2, 368-380.
Aytac, Hasan Et Al. "Tumor Necrosis Factor-alpha (TNF-α) −238 G/A Polymorphism Is Associated with the Treatment Resistance and Attempted Suicide in Schizophrenia," Immunological Investigations , vol.51, no.2, 368-380, 2022
Aytac, Hasan M. Et Al. "Tumor Necrosis Factor-alpha (TNF-α) −238 G/A Polymorphism Is Associated with the Treatment Resistance and Attempted Suicide in Schizophrenia." Immunological Investigations , vol.51, no.2, pp.368-380, 2022
Aytac, H. M. Et Al. (2022) . "Tumor Necrosis Factor-alpha (TNF-α) −238 G/A Polymorphism Is Associated with the Treatment Resistance and Attempted Suicide in Schizophrenia." Immunological Investigations , vol.51, no.2, pp.368-380.
@article{article, author={Hasan Mervan Aytac Et Al. }, title={Tumor Necrosis Factor-alpha (TNF-α) −238 G/A Polymorphism Is Associated with the Treatment Resistance and Attempted Suicide in Schizophrenia}, journal={Immunological Investigations}, year=2022, pages={368-380} }